Interaction of lipophilic VIP derivatives with recombinant VIP1/PACAP and VIP2/PACAP receptors

This publication has 27 references indexed in Scilit:

• In Vitro Properties of a High Affinity Selective Antagonist of the VIP1 Receptor
  Peptides, 1997
• Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating peptide (PACAP-27, but not PACAP-38) degradation by the neutral endopeptidase EC 3.4.24.11
  Biochemical Pharmacology, 1997
• The Long-Acting Vasoactive Intestinal Polypeptide Agonist RO 25-1553 Is Highly Selective of the VIP 2 Receptor Subclass
  Peptides, 1997
• Development of High Affinity Selective VIP1 Receptor Agonists
  Peptides, 1997
• Design and development of a vasoactive intestinal peptide analog as a novel therapeutic for bronchial asthma
  Biopolymers, 1995
• Properties of the VIP-PACAP type II receptor stably expressed in CHO cells
  Regulatory Peptides, 1994
• The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphoblastic membranes
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1991
• Preferential cleavage of amino- and carboxyl-terminal oligopeptides from vasoactive intestinal polypeptide by human recombinant enkephalinase (neutral endopeptidase, EC 3.4.24.11)
  Biochemical and Biophysical Research Communications, 1989
• Peptide Analogues of the Anaphylatoxin C3a; Syntheses and Properties
  Biological Chemistry Hoppe-Seyler, 1989
• Dysfunction of the Gastrointestinal Tract. Vasoactive Intestinal Peptide in Peristalsis and Sphincter Function
  Annals of the New York Academy of Sciences, 1988